Derangements in adrenergic–adipokine signalling establish a neurohormonal basis for obesity‐related heart failure with a preserved ejection fraction
M Packer - European journal of heart failure, 2018 - Wiley Online Library
Among patients with heart failure and a preserved ejection (HFpEF), obesity is associated
with a distinct phenotype that is characterized by adiposity‐driven plasma volume expansion …
with a distinct phenotype that is characterized by adiposity‐driven plasma volume expansion …
Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction
M Packer - European journal of heart failure, 2018 - pubmed.ncbi.nlm.nih.gov
Among patients with heart failure and a preserved ejection (HFpEF), obesity is associated
with a distinct phenotype that is characterized by adiposity-driven plasma volume expansion …
with a distinct phenotype that is characterized by adiposity-driven plasma volume expansion …
Derangements in adrenergic–adipokine signalling establish a neurohormonal basis for obesity‐related heart failure with a preserved ejection fraction
M Packer - European Journal of Heart Failure, 2018 - cir.nii.ac.jp
抄録< jats: p> Among patients with heart failure and a preserved ejection (HFpEF), obesity is
associated with a distinct phenotype that is characterized by adiposity‐driven plasma …
associated with a distinct phenotype that is characterized by adiposity‐driven plasma …
Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction.
M Packer - European Journal of Heart Failure, 2018 - europepmc.org
Among patients with heart failure and a preserved ejection (HFpEF), obesity is associated
with a distinct phenotype that is characterized by adiposity-driven plasma volume expansion …
with a distinct phenotype that is characterized by adiposity-driven plasma volume expansion …